Advertisement

Topics

HCS Capital Deploys $4MM into Growing InsurTech Opportunity, FIGO Pet Insurance

10:00 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
HCS Capital Partners (“HCS”) a Miami based Private Equity and operating firm, announced today it has completed a $4mm investment in FIGO Pet Insurance. This InsurTech investment marks the most recent for HCS, as they ...

Other Sources for this Article

HCS Capital Partners
Ryan M. Smith
r.smith@hcscapital.com

NEXT ARTICLE

More From BioPortfolio on "HCS Capital Deploys $4MM into Growing InsurTech Opportunity, FIGO Pet Insurance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...